NASOPHARYNGEAL NEOPLASM BENIGN

This adverse event was reported 6 times

NASOPHARYNGEAL NEOPLASM BENIGN is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DICHLORPHENAMIDE 2 0.0012
1 DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE 2 0.0001
2 TEMAZEPAM 1 0.0000
3 FLUDARABINE PHOSPHATE 1 0.0000
4 VEDOLIZUMAB 1 0.0000
5 CYCLOSPORINE 1 0.0000
6 METFORMIN ER 500 MG 2 0.0000
7 ADALIMUMAB 1 0.0000
See all drugs enriched for association with NASOPHARYNGEAL NEOPLASM BENIGN

These drug classes are most commonly taken by patients reporting NASOPHARYNGEAL NEOPLASM BENIGN:

# Drug class Count
0 Carbonic Anhydrase Inhibitor [EPC] 2
1 Benzodiazepine [EPC] 1
2 Calcineurin Inhibitor Immunosuppressant [EPC] 1
3 Integrin Receptor Antagonist [EPC] 1
See all common drug classes associated with NASOPHARYNGEAL NEOPLASM BENIGN

NASOPHARYNGEAL NEOPLASM BENIGN is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Carbonic Anhydrase Inhibitor [EPC] 2 0.0001
1 Integrin Receptor Antagonist [EPC] 1 0.0000
2 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
3 Benzodiazepine [EPC] 1 0.0000
See all drug classes enriched for association with NASOPHARYNGEAL NEOPLASM BENIGN